Mycophenolate Mofetil hydrochloride
Drug Details
- Generic Name
- Mycophenolate Mofetil hydrochloride
- Brand Names
- CellCept, Mycophenolate Mofetil
- Application Number
- NDA050758
- Sponsor
- Genentech, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE CELLCEPT [mycophenolate mofetil (MMF)] is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants. CELLCEPT is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. ( 1 )